Purchase textbook

Immune Checkpoint Inhibitors in Cancer,

Edition 1

Editors: Edited by Fumito Ito, MD, PhD and Marc Ernstoff, MD

Publication Date: 22 Aug 2018

0 Reviews

Legal Considerations

Unknown accessibility

Note

This product relies on 3rd party tooling which may impact the accessibility features visible in inspection copies. All accessibility features mentioned would be present in the purchased version of the title.

Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.

Key Features

Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages.
Helps you translate current research and literature into practical information for daily practice.

Presents information logically organized by disease site.

Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks.

Consolidates today’s available information on this timely topic into one convenient resource.

About the author

Edited by Fumito Ito, MD, PhD, Associate Professor of Oncology, Department of Surgical Oncology, Member, Center for Immunotherapy, Roswell Park Cancer Institute; Associate Professor of Surgery, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York; Marc Ernstoff, MD, Professor and Chair, Department of Medicine, Senior Vice President for Clinical Investigation, The Katherine Anne Gioia Chair of Medicine, Roswell Park Cancer Institute and Chief, Division of Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffaclo, New York

1. Tumor Immunology

2. Melanoma and Other Skin Cancers

3. Thoracic Malignancies

4. Gastrointestinal, Hepatobiliary, and Pancreatic Malignancies

5. Cancers of the Head and Neck

6. Urologic Malignancies

7. Gynecologic Malignancies

8. Breast Cancer

9. Hematologic Malignancies

10. Pediatric Malignancies

11. Toxicities Associated with Immune Checkpoint Inhibitors

12. Future of Immune Checkpoint Inhibitors

Title Reviews

"Overall, this is an informative and authoritative book that includes experiences from clinicians and scientists working at some of the most renowned cancer centers in the world."

-Ravi Salgia, MD, PhD (City of Hope) Doody's Score: 100-5 Stars!

Immune Checkpoint Inhibitors in Cancer,

Editors: Edited by Fumito Ito, MD, PhD and Marc Ernstoff, MD

Description

Key Features

About the author

Title Reviews

Related Titles